Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors
Abstract Background Biologic disease-modifying antirheumatic drugs (bDMARDs) have changed the treatment of juvenile idiopathic arthritis (JIA) patients notably, as bDMARDs enable substantially more patients to achieve remission. When sustained remission is achieved, tapering or even discontinuation...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Kniha |
| Vydáno: |
BMC,
2022-12-01T00:00:00Z.
|
| Témata: | |
| On-line přístup: | Connect to this object online. |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Jednotka 1 | Dostupné |